N-(3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)-7-ethoxy-3-methyl-6-((1-methylpyrrolidin-2-ylidene)amino)quinolin-4-amine
98%
- Product Code: 220652
CAS:
1144516-21-1
Molecular Weight: | 527.02 g./mol | Molecular Formula: | C₂₉H₂₇ClN₆O₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used as a potent inhibitor in targeted cancer therapies, particularly in the treatment of certain tyrosine kinase-driven tumors. It interferes with abnormal signaling pathways in cancer cells, especially those involving EGFR and HER2 mutations, helping to suppress tumor growth and proliferation. Its structure allows for high selectivity and improved pharmacokinetic properties, making it suitable for oral administration in chronic treatment regimens. Commonly investigated in non-small cell lung cancer and other solid tumors where resistance to earlier-generation inhibitors has developed. Shows activity against both wild-type and resistant mutant forms of kinase targets, contributing to its use in second-line therapeutic settings.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
10mg | 10-20 days | ฿6,460.00 |
+
-
|
N-(3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)-7-ethoxy-3-methyl-6-((1-methylpyrrolidin-2-ylidene)amino)quinolin-4-amine
Used as a potent inhibitor in targeted cancer therapies, particularly in the treatment of certain tyrosine kinase-driven tumors. It interferes with abnormal signaling pathways in cancer cells, especially those involving EGFR and HER2 mutations, helping to suppress tumor growth and proliferation. Its structure allows for high selectivity and improved pharmacokinetic properties, making it suitable for oral administration in chronic treatment regimens. Commonly investigated in non-small cell lung cancer and other solid tumors where resistance to earlier-generation inhibitors has developed. Shows activity against both wild-type and resistant mutant forms of kinase targets, contributing to its use in second-line therapeutic settings.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :